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Background: Chronic airway infection by Pseudomonas aeruginosa considerably
contributes to lung tissue destruction and impairment of pulmonary function in
cystic-fibrosis (CF) patients. Complex interplays between P. aeruginosa and other co-
colonizing pathogens including Staphylococcus aureus, Burkholderia sp., and Klebsiella
pneumoniae may be crucial for pathogenesis and disease progression.
Methods: We generated a library of PA14 transposon insertion mutants to identify
P. aeruginosa genes required for exploitative and direct competitions with S. aureus,
Burkholderia cenocepacia, and K. pneumoniae.
Results:Whereas wild-type PA14 inhibited S. aureus growth, two transposon insertions
located in pqsC and carB, resulted in reduced growth inhibition. PqsC is involved
in the synthesis of 4-hydroxy-2-alkylquinolines (HAQs), a family of molecules having
antibacterial properties, while carB is a key gene in pyrimidine biosynthesis. The carB
mutant was also unable to grow in the presence of B. cepacia and K. pneumoniae but
not Escherichia coli and S. epidermidis. We further identified a transposon insertion in
purF, encoding a key enzyme of purine metabolism. This mutant displayed a severe
growth deficiency in the presence of Gram-negative but not of Gram-positive bacteria.
We identified a beneficial interaction in a bioA transposon mutant, unable to grow on
rich medium. This growth defect could be restored either by addition of biotin or by
co-culturing the mutant in the presence of K. pneumoniae or E. coli.
Conclusion: Complex interactions take place between the various bacterial species
colonizing CF-lungs. This work identified both detrimental and beneficial interactions
occurring between P. aeruginosa and three other respiratory pathogens involving several
major metabolic pathways. Manipulating these pathways could be used to interfere with
bacterial interactions and influence the colonization by respiratory pathogens.
Keywords: direct competition, exploitative competition, respiratory pathogens, Pseudomonas aeruginosa,
beneficial interactions, Staphylococcus aureus
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Introduction
The composition of the microbial respiratory ﬂora of cys-
tic ﬁbrosis (CF) patients changes with age; Haemophilus
influenzae and Staphylococcus aureus being present mainly
in young children, while Pseudomonas aeruginosa, S. aureus,
and Burkholderia sp. predominate in older patients (Goss
and Burns, 2007; Cox et al., 2010; Lipuma, 2010). At the
age of 20, 60–70% of CF-patients present intermittent col-
onization by P. aeruginosa (Folkesson et al., 2012) which
progressively evolves toward a chronic colonization, that entails
progressive lung tissue damage and impairment of pulmonary
function. The disappearance of the early colonizing species
may be explained by antibiotic treatments or by competition
between co-colonizing microorganisms. Many ecological fac-
tors, including host immune responses as well as the pres-
ence of co-colonizing species interacting with P. aeruginosa
by competition and/or cooperation, determine the dynam-
ics of lung colonization. Bacterial interference occurs either
via direct competition characterized by an active mechanism
including the type VI secretion systems (Pukatzki et al., 2006;
Basler et al., 2013) and production of competitor molecules
(siderophores, secondary metabolites, toxins), or via exploita-
tive competition where one organism consumes the resources
of another (Cornforth and Foster, 2013; Boon et al., 2014).
For example, P. aeruginosa can lyse S. aureus to obtain
iron under iron-starvation conditions using LasA protease
(Mashburn et al., 2005), and 4-hydroxy-2-heptylquinoline N-
oxide (HQNO) allows P. aeruginosa to inhibit the cytochrome
oxidase of S. aureus (Lightbown and Jackson, 1954; Machan et al.,
1992; Toder et al., 1994). Furthermore, recent results demon-
strated that compounds such as phenazines inhibit methicillin-
resistant S. aureus (MRSA; Cardozo et al., 2013). Besides
active competition, regulatory eﬀects induced for instance
by the resident ﬂora can induce the expression of impor-
tant virulence and metabolic genes in P. aeruginosa (Duan
et al., 2003). In addition, positive interactions can also occur
between microorganisms during polymicrobial infections. For
example, P. aeruginosa can induce the formation of small
colony variants in S. aureus, leading to an increased resis-
tance of the latter to aminoglycoside antibiotics (Hoﬀman
et al., 2006). This indicates that interspecies competition
and cooperation play an important role in shaping compo-
sition and structure of polymicrobial bacterial populations,
thereby potentially inﬂuencing disease progression. Increasing
our understanding of these interactions is crucial (Bragonzi
et al., 2012) and might lead to the identiﬁcation of new
targets aiming at manipulating interactions inside polymicro-
bial communities to the disadvantage of pathogens such as
P. aeruginosa.
In this perspective we developed a broad genetic screen to
identify P. aeruginosa genes required for direct and exploita-
tive competition. We searched for P. aeruginosamutants aﬀected
in growth in the presence of S. aureus, Klebsiella pneumo-
niae, or B. cepacia. In addition, we examined P. aeruginosa
mutants altered in their capacity to inhibit growth of S.
aureus.
Materials and Methods
Bacterial Strains, Growth Conditions and
Media
All P. aeruginosa mutants used in this study are derived from
the clinical strain PA14 (Rahme et al., 1995; Table 1). All genetic
manipulations were performed in Escherichia coli strain DH10B.
E. coli strain SM10-λpir was used for conjugating plasmids into
P. aeruginosa. Three bacterial pathogens were used for the initial
screening: the S. aureus clinical strain COL (Dyke et al., 1966),
a clinical Burkholderia cenocepacia isolate (University Hospitals
of Geneva) and a non-capsulated K. pneumoniae strain (labora-
tory collection). The S. epidermidis and the E. coli strains were
isolated from tracheal aspirates of two CF patients followed at the
University Hospitals of Geneva (Geneva, Switzerland).
When required, plates were supplemented with 1 mM uracil,
1 mM arginine, or 2 mg/L biotin (ﬁnal concentrations). For
growth under hypoxic conditions, LB plates were supplemented
with 5 mM KNO3 and incubated in a jar using the GasPak Plus
kit (BBL) (ﬁnal O2 concentration < 0.2%).
Generation of the P. aeruginosa PA14
Transposon (Tn) Mutant Library
The E. coli SM10-λpir donor strain containing pBT20
(Kulasekara et al., 2005) and the recipient P. aeruginosa
PA14 were grown overnight at 37◦C with shaking (250 rpm)
in LB-broth. 200 μL of the donor and 100 μL of the recipient
culture were mixed and centrifuged at 6,000 rpm for 2 min. The
pellet was resuspended in 20 μL of LB and deposited on an LB
agar plate. After 5 h of incubation at 37◦C, cells were resuspended
in 1 mL 0.9% NaCl and 100 μL of the suspension were plated
on LB agar medium containing gentamicin (50 mg/L) and
chloramphenicol (10 mg/L). To test for random distribution of
Tn-insertions, 200 transconjugants were picked and streaked
on minimal M9-salts medium supplemented with 0.2% glucose
and 1 mM MgSO4 and on an LB-agar plate. Approximately 1%
of clones were auxotrophic, which is agreement with a random
transposition event.
Growth Competition Screening
Overnight cultures of bacterial competitors were adjusted to
OD600 = 0.5. A 500 μL aliquot of ﬁvefold (S. aureus and S. epi-
dermidis) and 100-fold (B. cepacia, K. pneumoniae, and E. coli)
dilutions were plated on agar plates. Bacterial lawns were incu-
bated 2 h at 37◦C. Overnight cultures of P. aeruginosa transposon
mutants were adjusted to OD600 = 2 and 1μL of each culture was
spotted on the competitor lawns using a 48-pin inoculator. As
control, cells were spotted on a plate without competitors. Plates
were incubated 18 h at 37◦C. Mutants were initially screened for:
(i) an alteration of the inhibition zone on the S. aureus lawn
on Mueller Hinton agar, and (ii) an alteration of P. aeruginosa
growth on lawns of B. cepacia and K. pneumoniae on LB-agar.
Identification of the Transposon Insertion
Site
The transposon insertion site was identiﬁed by a two-step semi-
random PCR (Friedman and Kolter, 2004; Kulasekara et al.,
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TABLE 1 | Plasmids and strains.
Plasmids or strains Description Reference
Plasmids
pIApX2 Broad-host-range cloning vector, pUCP20 derivative I. Attree (Grenoble, France;
West et al., 1994)
pME3087 Mobilizable suicide vector, ColE1 Voisard et al. (2007)
pMMB207 Expression plasmid with inducible tac/lacUV5 promoter Morales et al. (1991)
pPqsCDE pqsCDE PCR fragment cloned into pIApX2 by using XbaI (Roche) and HindIII (Roche) This study
pCarB carB PCR fragment cloned into pIApX2 by using HindIII (Roche) and BamHI (Roche) This study
pBioA bioA PCR fragment cloned into pMMB207 by using KpnI (NEB) and BamHI (Roche) This study
pPurF purF PCR fragment cloned into pMMB207 by using KpnI (NEB) and BamHI (Roche) This study
Strains
PA14 Clinical isolate UCBPP-PA14 Rahme et al. (1995)
PA14 carB::Tn Transposon inserted into the carB gene This study
PA14 pqsC::Tn Transposon inserted into the pqsC gene This study
PA14 purF::Tn Transposon inserted into the purF gene This study
PA14 bioA::Tn Transposon inserted into the bioA gene This study
PA14 carB::Tn pCarB carB-disrupted Pseudomonas aeruginosa containing the pCarB complementation plasmid This study
PA14 pqsC::Tn pPqsCDE pqsC-disrupted P. aeruginosa containing the pPqsCDE complementation plasmid This study
PA14 purF::Tn pPurF purF-disrupted P. aeruginosa containing the pPurF complementation plasmid This study
PA14 bioA::Tn pBioA bioA-disrupted P. aeruginosa containing the pBioA complementation plasmid This study
PA14 carB::Tn pIApX2 carB-disrupted P. aeruginosa containing the pIApX2 plasmid This study
PA14 pqsC::Tn pIApX2 pqsC-disrupted P. aeruginosa containing the pIApX2 plasmid This study
PA14 purF::Tn pMMB207 purF-disrupted P. aeruginosa containing the pMMB207 plasmid This study
PA14 bioA::Tn pMMB207 bioA-disrupted P. aeruginosa containing the pMMB207 plasmid This study
PA14  lasA LasA-deleted P. aeruginosa PA14 strain This study
PAO1  pqsA pqsA::lux PqsA-deleted P. aeruginosa PAO1 strain with a copy of the pqsA promoter linked to the
luxCDABE genes and inserted into a neutral site in the chromosome
Fletcher et al. (2007)
PA14 mvfR− Mutated PA14 strain containing a nonsense point mutation in mvfR Cao et al. (2001)
PA14 pqsA− Mutated PA14 strain containing a non-polar deletion of pqsA Deziel et al. (2004)
PA14 pqsH− Mutated PA14 strain containing a aacC1 cassette inserted into pqsH Xiao et al. (2006a)
PA14 pqsL− Isogenic non-polar pqsL deletion mutant Lepine et al. (2004)
Escherichia coli SM10-λpir RP4-2-Tc::Mu recA, pir lysogen KmR Simon et al. (1983)
Staphylococcus aureus COL Clinical strain, MRSA Dyke et al. (1966)
Burkholderia cenocepacia Clinical strain University Hospitals of
Geneva
Klebsiella pneumoniae Non-capsulated Laboratory collection
E. coli Clinical strain from CF-patient This study
S. epidermidis Clinical strain from CF-patient This study
2005). The ﬁrst round PCR reaction contained dNTPs (0.25 mM
ﬁnal), Taq Buﬀer (1X ﬁnal, Sigma), DMSO (5% ﬁnal concen-
tration), Taq polymerase (2.5 U/reaction, Sigma), and primers
MCL195 and ARB1 (Table 2). Four microliters of bacterial lysate
served as template. PCR cycling conditions were as follows: 95◦C
for 3 min, 36 cycles of 95◦C for 20 s, 30 to 48◦C for 40 s with
a 0.5◦C increase per cycle, 72◦C for 1 min and a ﬁnal exten-
sion at 72◦C for 5 min. In the second round PCR reaction the
nested primers ARB2 and MCL210 were used (Table 2). PCR
conditions were as follows: 95◦C for 3 min, 30 cycles of 95◦C
for 30 s, 50◦C for 30 s, 72◦C for 1 min and a ﬁnal extension
of 72◦C for 4 min. PCR products were visualized on a 1.6%
agarose gel. The most intense bands were extracted and puri-
ﬁed (GeneJet Gel extraction kit, ThermoScientiﬁc). The PCR
products were then submitted to DNA sequencing (Fasteris
SA, Geneva, Switzerland) using the nested primers ARB2 and
MCL210. Each sequence was aligned to the PA14 genome
sequence in the Pseudomonas database (Winsor et al., 2011).
Conﬁrmation of the transposon insertion was done by PCR using
gene and/or transposon speciﬁc primers. PCR cycling conditions
were: (i) activation: 95◦C for 2 min, (ii) denaturation: 95◦C for
20 s, annealing: 57◦C for 30 s, extension: 72◦C for 1 min and
30 s, (iii) ﬁnal extension: 72◦C for 4 min. Step 2 was repeated
27 times. PCR products were puriﬁed and submitted to DNA
sequencing.
Exoproduct Analysis
Rhamnolipid production was assessed following a previously
described protocol (Kohler et al., 2000). Plates were incubated
18 h at 37◦C, 24 h at room temperature and then 16 h at
4◦C. The diameter of the rhamnolipid-containing halo formed
around the bacterial colony was measured and compared with
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TABLE 2 | Primers used in this study






Confirmation of the transposon insertion site and complementations∗
PurF-Kpn purF ACAGGTACCAGTGATTTTGGCGGGACAC 0.6
PurF-BamHI ACAGGATCCCCAGGGTGTCGAAGGCC 0.6
BioA-Kpn bioA ACAGGTACCTGAACACCCCCAACATGAGA 0.6
BioA-R_BamHI ACAGGATCCGATTCGAGGGTAGTGGCGAC 0.6
CarB-F_BamHI carB ACAGGATCCGTTCGTCGATCCCGGCTA 0.6
CarB-R_HindIII ACAAAGCTTTCGGCGTTTTCCTTGAGG 0.6
pqsC-Xba pqsCDE ACACTCTAGATTCGAACTGGCGTCGCAAC 0.6
pqsC-Hind ACACAAGCTTTCTTCCAGTCGATAGCCAACC 0.6
lasA deletion∗
LasAF-Eco 5′ lasA region CCCGGAATTCAGGATAACGTCGGCATGGAC 0.6
LasAR-Bam CCGCGGATCCTGCTCCAGGTATTCGCTCTTG 0.6
LasAF-Bam 3′ lasA region CCGCGGATCCACCAGATCCAGGTGAGCAACG 0.6
LasAR-Hind CCCCAAGCTTTCGGAGTCCGGCTACTACGC 0.6
∗Restriction enzyme recognition sites are underlined
that produced by the reference strain PA14. Determinations were
done in duplicates.
Elastase activity was determined using the Elastin Congo Red
assay with modiﬁcations (Pearson et al., 1997). Overnight cul-
tures of P. aeruginosa strains were prepared in LB medium
supplemented with 1 mM uracil to optimize the growth of the
strain PA14 carB::Tn. Cultures were grown for 7 h at 37◦C in
PB medium (Essar et al., 1990). The OD600 was measured and
elastase activity determined in supernatants using the Elastin
Congo Red assay measuring absorption at OD495. All determi-
nations were done in triplicate and expressed as the ratio of
OD495/OD600.
Extra-Chromosomal Complementations
The coding regions of carB, pqsCDE, bioA, and purF including
100 nucleotides upstream of the start codon were ampliﬁed by
PCR from PA14 genomic DNA using the primers listed inTable 2
and following the same PCR conditions as described above. PCR
products were puriﬁed and cloned into vectors pIApX2 (pqsCDE,
carB) or pMMB207 (purF, bioA; Morales et al., 1991; West et al.,
1994;Table 1). 1.5μg of each vector and insert were digested with
the appropriate restriction enzymes and buﬀers in a ﬁnal volume
of 25 μL (Table 1). After puriﬁcation on agarose gel (GeneJet Gel
extraction kit, ThermoScientiﬁc), vectors and inserts were ligated
(T4 DNA ligase, Promega). E. coli DH10B thermo-competent
cells were transformed with the ligation mixture and transfor-
mants selected on LB plates supplemented with 100μg/mL ampi-
cillin (pqsCDE, carB) or 15μg/mL chloramphenicol (purF, bioA).
The resulting plasmids pCarB and pPqsCDE were electroporated
into the corresponding PA14 Tn-mutants and selected on LB-
agar plates supplemented with 200μg/mL carbenicillin. Plasmids
pPurF and pBioA were transferred into the corresponding PA14
Tn-mutants by triparental mating using pRK2013 as a helper
plasmid (Figurski and Helinski, 1979). Transconjugants were
selected on LB-agar plates supplemented with 250 μg/mL chlo-
ramphenicol and 25 μg/mL gentamycin to counterselect E. coli
donor strains.
Construction of the P. aeruginosa lasA
Mutant
A lasA deletion mutant was constructed by homologous recom-
bination using plasmid pME3087 (Voisard et al., 2007). For
the 5′-region PCR fragment, we used dNTP (0.2 mM ﬁnal),
Taq Buﬀer (1X ﬁnal, Sigma), DMSO (5% ﬁnal), Taq polymerase
(2.5 U/reaction), and 4 μL of PA14 lysate. PCR conditions were
as follows: one cycle of 2 min at 95◦C, 27 cycles of 20 s at 95◦C,
30 s at 57◦C, 1 min at 72◦C followed by a ﬁnal extension of 4 min
at 72◦C. For the 3′-region PCR fragment, we used dNTP (0.2 mM
ﬁnal), PFU Buﬀer (1X ﬁnal), DMSO (5% ﬁnal), PFU polymerase
(2.5 U/reaction), and 4 μL of PA14 bacterial lysate. PCR condi-
tions were as follows: one cycle of 95◦C for 2min, 30 cycles of 20 s
at 95◦C, 30 s at 55◦C, 1 min at 72◦C, followed by a ﬁnal extension
of 4 min at 72◦C. The 5′-region and the 3′ region fragments were
digested with BamHI. Both fragments were ligated and PCR re-
ampliﬁed using primers LasAF-Eco and LasAR-Hind (Table 2).
The generated 1.6 kbp fragment was digested using EcoRI and
HindIII restriction enzymes and cloned into plasmid pME3087.
The resulting plasmid plasA1 was introduced into E. coli strain
SM10lpir for subsequent conjugation into P. aeruginosa PA14.
Transductants were selected on M9-agar plates supplemented
with 25 μM citrate and 1 mM MgSO4 and 75 μg/mL tetracy-
cline (Tc). Individual colonies were repuriﬁed on LB-agar plates
containing 75 μg/mL Tc. Putative lasR deletion mutants gen-
erated after the second recombination event were enriched by
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carbenicillin-treatment as described previously (Voisard et al.,
2007). Surviving cells, which were Tc-susceptible were screened
by PCR for loss of a 300 bp fragment in the lasA gene. One of
three clones was selected for further analysis.
Inhibition and Lytic Activity of P. aeruginosa
Supernatants on S. aureus
We measured both inhibition of the S. aureus growth as well as
lysis of S. aureus cells by P. aeruginosa supernatants.
The inhibition capacity of P. aeruginosa supernatants on S.
aureus growth was tested in liquid. Overnight cultures of P.
aeruginosa grown inMH-broth were centrifuged and the resulted
supernatants were ﬁltered (0.22 μm, Millipore). An overnight
culture of S. aureus strain COL was adjusted to an OD600 of
0.1 in MH-broth. 100 μL of this bacterial suspension was incu-
bated with 100 μL of P. aeruginosa supernatant. All mixtures
were incubated in triplicate at 37◦C with intermittent shaking
and OD600 was recorded for 10 h in a plate reader (BioTek
Synergy H1).
The lytic activity of P. aeruginosa overnight culture super-
natants on S. aureus was tested on LB medium, supplemented
or not with 1 mM uracil. The overnight cultures of P. aerug-
inosa were adjusted to the same OD600 before pelleting cells
by centrifugation (6,000 × g, 10 min). Supernatants were ﬁl-
tered (0.22 μm) and used immediately. An overnight culture
of S. aureus strain COL was adjusted to OD600 = 1 in 0.02 M
Tris-HCl pH 7.5 and cells were inactivated by heating at 95◦C
for 10 min. 100 μL of the S. aureus bacterial suspension was
incubated with 100 μL of ﬁltered P. aeruginosa supernatants.
Mixtures were incubated at 37◦C with intermittent shaking
and OD600 was recorded during 8 h in a plate reader (BioTek
Synergy H1).
Quantification of PQS Production
To test whether S. aureus aﬀects PQS production by P. aerugi-
nosa, an overnight culture of S. aureus strain COL was adjusted
to an OD600 = 0.1 in LB medium. 190 uL of this dilution was
deposited in a 96 well plate and incubated for 2 hwithout shaking.
During this incubation, P. aeruginosa overnight cultures were
centrifuged (6,000 rpm, 3 min) and the pellet adjusted to an
OD600 = 2 in 0.9% NaCl. 5 μL of this cell suspensions of the
P. aeruginosa PA14 and PA14 carB mutant were combined with
5 μL of the cell suspension of the PQS-indicator strain PA14
pqsA pqsA::lux culture (Fletcher et al., 2007) and added to the
190 μL of the pre-incubated S. aureus cultures. The microtiter
plate was incubated at 37◦C with intermittent shaking and opti-
cal density at 600 nm and luminescence were recorded after 6 h.
Experiments were done in duplicate.
Growth Competition Assay with
Supernatants of Competitor Cultures
Pseudomonas aeruginosa cultures were also spotted onMH-plates
seeded with 500 μl of ﬁltered supernatants from overnight com-
petitor cultures. Overnight (18 h) cultures of competitor bacteria
were centrifuged 10 min at 6,000 rpm. Supernatants were ﬁltered
(0.22 μm) and 500 μL of the ﬁltrate was spread on agar plates. P.
aeruginosa cultures were prepared as described above.
Results
Generation of the P. aeruginosa PA14
Transposon Insertion Library and Selection
of Mutants Affected in their Capacity to
Compete with other Respiratory Pathogens
We generated a library of 2,288 transposon insertion mutants
in P. aeruginosa strain PA14. Three bacterial pathogens also
commonly found in the lungs of CF patients were selected for
the initial competition screening: S. aureus, B. cepacia, and K.
pneumoniae. The PA14 mutant library was screened for: (i) an
alteration of the inhibition zone produced by P. aeruginosa on a
lawn of S. aureus (Figure 1A), and (ii) an alteration of P. aerug-
inosa growth in the presence of B. cepacia and K. pneumoniae
(Figure 1B). Based on this screening, 64 mutants were retained
displaying an altered inhibition zone (35 mutants) or growth
(25 mutants) or both (4) in the presence of competitors when
compared to wild-type PA14. Each of the selected mutants was
re-tested in quadruplicates and four yielded reproducible pheno-
types. Two mutants showed a reduction of the inhibition zone
on a lawn of S. aureus, while the two others were aﬀected in
growth on lawns of K. pneumoniae or B. cepacia. Growth of
these mutants was not aﬀected on agar plates in the absence of
competitors (data not shown).
Role of the P. aeruginosa pqs Pathway
During Competition with S. aureus
We determined the transposon insertion site in the P. aerugi-
nosa clone most aﬀected in inhibition of S. aureus growth, by
a two-step semi-random PCR. The transposon was inserted at
nucleotide position 136 of the pqsC gene, which belongs to the
pqsABCDE operon (Xiao et al., 2006b). A pqsC mutant is deﬁ-
cient for the production of 4-hydroxy-2-alkylquinolines (HAQs;
Dulcey et al., 2013). We complemented our pqsC transposon
mutant by introducing a plasmid-encoded copy of the pqsCDE
genes from PA14. The complemented mutant showed a partial
restoration of the wild-type inhibition zone (Figure 2A). Because
pqsC is part of a multigene operon, we tested the phenotype of
strains mutated in other genes belonging to the PQS biosynthe-
sis pathway. As expected, PA14 derivatives mutated in pqsA or
mvfR (pqsR), both deﬁcient in HAQ biosynthesis, did not inhibit
S. aureus growth (Figure 2A). The same phenotype was observed
for the pqsH mutant.
To test whether these phenotypes were limited to growth
on solid medium, supernatants of P. aeruginosa overnight cul-
tures were incubated together with a cell suspension of the
S. aureus strain COL. Whereas supernatant of wild-type PA14
inhibited growth of S. aureus, supernatants from pqsA, pqsC,
mvfR, and pqsH mutants showed no inhibitory activity. In agree-
ment with the data obtained on solid medium, the pqsL mutant
showed a partial inhibition of S. aureus growth in liquid medium
(Figure 2B).
The LasA staphylolytic protease of P. aeruginosa cleaves the
pentaglycine cross-links in the peptidoglycan of S. aureus leading
to cell lysis (Kessler et al., 1993). We therefore tested the super-
natant of a lasAmutant in competition with S. aureus, which did
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FIGURE 1 | Selection of Pseudomonas aeruginosa mutants affected
in competition with bacterial pathogens. (A) P. aeruginosa
Tn-mutants were spotted on Staphylococcus aureus bacterial lawn on
MH-agar plate. This panel shows an example of a mutant displaying an
altered inhibition zone compared to the others, indicating that this
mutant is not able to compete with S. aureus. (B) P. aeruginosa
Tn-mutants were spotted on LB agar plate with or without Klebsiella
pneumoniae. The unbroken line shows a mutant drastically affected by
the presence of K. pneumoniae whereas it had a normal growth on
plate without competitor.
not alter the wild-type inhibition proﬁle comparable to the one
of the wild-type PA14 in our model (Figure 2B). These results
demonstrate that the observed inhibition proﬁle is not the conse-
quence of the expression of LasA, but can be associated to the
pqs pathway activity in wild-type PA14. To further distinguish
between inhibition and lytic activity, we performed the same
experiment on heat-inactivated staphylococcal cells (Figure 2C).
Optical density related to S. aureus cells rapidly decreased after
addition of PA14 supernatants. We observed the same proﬁle
with the pqsC mutant, indicating that HAQs do not contribute
to S. aureus cell lysis but to growth inhibition. In contrast, PA14
 lasA was aﬀected in its capacity to lyse S. aureus as expected
from previous reports.
Because products of the PQS pathway are known to suppress
growth in Gram-positive bacteria by inhibiting the respiratory
chain in aerobic condition, we hypothesized that this pheno-
type may be abolished under hypoxic conditions. As expected,
we observed no inhibition zone even for PA14 under hypoxic
conditions (Figure 2D). Because nitrate is a key compound for
the growth of P. aeruginosa under hypoxic conditions, we per-
formed the experiment without and with addition of KNO3 as
terminal electron acceptor. However, addition of KNO3 had no
eﬀect on the phenotype. This suggests that HAQs are unlikely
to play a role in S. aureus growth inhibition under hypoxic
conditions.
Taken together our experiments suggest that the lasA gene
product is responsible for the lytic activity of P. aeruginosa, while
HAQs are responsible for growth inhibition of S. aureus under
aerobic conditions.
Impact of the carB Mutation During Direct
Competition between P. aeruginosa and
S. aureus
The second mutant aﬀected in its capacity to inhibit growth,
and therefore to compete with S. aureus, harbored the transpo-
son inserted at position 1,632 of the carB gene (PA14_62910),
encoding the large subunit of the carbamoyl phosphate synthase
(Winsor et al., 2011). CarB is involved in the pyrimidine pathway
leading to uracil synthesis. Indeed, supplementation with uracil
restored growth of the carBmutant, but not the S. aureus growth
inhibition (Figure 3A). Recently, pyrF, another gene required
for uracil and pyrimidine synthesis was shown to aﬀect the
quorum-sensing (QS)-circuit in strain PA14 (Ueda et al., 2009).
We therefore tested the QS-dependent virulence factor produc-
tion in the carB mutant. However, we observed no diﬀerence in
rhamnolipid (Figure 3B) and elastase production (Figure 3C)
between the carBmutant and the wild-type PA14. To determine if
the eﬀect observed with the carBmutant during competition with
S. aureuswas due to an alteration of the pqs pathway wemeasured
the production of PQS by quantifying luminescence produced by
the PAO1pqsA pqsA::lux reporter strain. The quantity of lumi-
nescence produced was identical between the carB mutant and
the wild-type PA14 strain, indicating that carB does not aﬀect the
PQS production (Figure 3D) during competition with S. aureus.
These results suggest that carB is required for inhibition of S.
aureus growth, through a QS-independent mechanism.
Role of the carB Gene During Competition
between P. aeruginosa, B. cepacia, and
K. pneumoniae
Two transposon mutants of P. aeruginosa were aﬀected in their
growth in the presence of B. cepacia and K. pneumoniae as com-
petitors. One of these mutants was the carB mutant described
above. This growth defect was complemented by the addition of
a plasmid-encoded copy of carB, as well as by the addition of
uracil (Figure 4A). Remarkably, growth of the carB mutant was
not aﬀected when competing with E. coli and S. epidermidis (data
not shown). In contrast the addition of arginine alone, the second
ﬁnal product of this metabolic pathway (Figure 5), had no impact
on the growth of the carB mutant (Figure 4B). To determine
whether soluble factors secreted by the competitors could be
involved, we plated supernatants of bacterial competitors on
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FIGURE 2 | Continued
FIGURE 2 | Continued
Role of the pqs pathway of P. aeruginosa in direct competition with
S. aureus. (A) Effect of pqsC disruption on the inhibition of S. aureus growth.
Spots of P. aeruginosa cultures were deposited on LB agar plates seeded with
a lawn of S. aureus strain COL. Inhibition zone diameters were measured,
normalized against the diameter of the corresponding spots and expressed as
a percentage against the wild-type PA14 values. Error bars are standard
deviations calculated on at least four replicates. Statistical significance was
determined by using a t-test with unequal variances (∗p < 0.01). (B) Inhibition
activity of P. aeruginosa supernatants on S. aureus growth. Supernatants of
P. aeruginosa overnight cultures were incorporated on S. aureus cells. S.
aureus growth (OD600) was monitored during 10 h at 37◦C in presence to
these supernatants. (C) Lytic activity of P. aeruginosa supernatants on
inactivated S. aureus cells. Supernatants of P. aeruginosa overnight cultures
were incorporated on heat-inactivated S. aureus cells. OD600 was monitored
during 8 h at 37◦C in presence to these supernatants to evaluate S. aureus
lysis. (D) Role of the pqs pathway in hypoxic conditions. Spots of P.
aeruginosa cultures were deposited on LB agar plates cover by a S. aureus
lawn. Plates were incubated during 48 h in hypoxic conditions.
LB-agar plates prior to P. aeruginosa spotting. Culture super-
natants of B. cepacia andK. pneumoniae did not aﬀect the growth
of the carB mutant, suggesting that the presence of metabol-
ically active competing bacteria is required to repress growth
of this mutant (Figure 4A). Taken together, these data demon-
strate that the carB gene, and by analogy the uracil/pyrimidine
biosynthesis, is an essential metabolic pathway for the competi-
tion of P. aeruginosa against B. cepacia, K. pneumoniae, and S.
aureus.
Effect of the purF Mutation on
the P. aeruginosa Growth in Presence of
B. cepacia, K. pneumoniae, and E. coli
The second mutant with a growth defect in the presence of com-
petitors had the transposon inserted at position 264 of the purF
(PA14_23920) gene, encoding an amidophosphoribosyl trans-
ferase. This protein is a key enzyme of purine metabolism,
supplying nucleotides for DNA and RNA synthesis (Sampei and
Mizobuchi, 1988). The purF::Tn mutant did not grow when
cells were spotted on plates containing lawns of B. cepacia, K.
pneumoniae, and E. coli (Figure 4C). This alteration was com-
plemented by the addition of a plasmid-encoded copy of the purF
gene. In contrast, the purF mutant showed normal growth in the
presence of S. epidermidis and S. aureus (data not shown). As
observed above for the carBmutant, culture supernatants of com-
peting bacteria did not aﬀect growth of the purF-disrupted strain
(Figure 4C). This suggests that the purF gene is essential for P.
aeruginosa growth in presence of the B. cepacia, K. pneumoniae,
and E. coli.
Role of the Biotin Synthesis Pathway
on Beneficial Interactions between
P. aeruginosa and other Respiratory
Pathogens
To determine if growth of P. aeruginosa can be promoted by
the presence of other bacterial pathogens, we screened the trans-
poson library for mutants that grew better in the presence of
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a competitor than in its absence on rich medium. We iden-
tiﬁed one transposon mutant that grew poorly on MH-agar,
but showed wild-type growth in the presence of K. pneumo-
niae and E. coli (Figure 4D). This growth “enhancement” was
not seen in the presence of B. cepacia, S. epidermidis, and S.
aureus bacterial lawns (data not shown). We identiﬁed the trans-
poson insertion in this mutant at position 474 of the bioA
(PA14_05460) gene, encoding an adenosylmethionine-8-amino-
7-oxononanoate aminotransferase, involved in the biotin biosyn-
thesis pathway (Stoner and Eisenberg, 1975). Indeed the addition
of biotin, as well as extra-chromosomic complementation with
the bioA gene, restored growth of the bioA-disrupted mutant
(Figure 4D). Finally, growth of the bioA transposon mutant
was not restored by supernatants of K. pneumoniae and E.
coli, suggesting that the presence of metabolically active cells of
these organisms is required to complement the growth deﬁcit
(Figure 4D).
Discussion
Our study identiﬁed metabolic pathways involved in either detri-
mental or beneﬁcial interactions between P. aeruginosa and four
bacterial respiratory pathogens. By screening a transposon library
of 2,288 mutants in PA14, we identiﬁed mutants displaying
altered growth inhibition, or growth phenotypes in the presence
of co-colonizing bacterial species. We found that both pqsC and
carB, responsible, respectively, for HAQ and uracil/pyrimidine
synthesis, play an essential role in the direct competition of
P. aeruginosa with S. aureus. Secondly, we identiﬁed carB and
purF, the latter involved in purine synthesis, as essential for
exploitative competition against K. pneumoniae and B. cenocepa-
cia (Figure 5). Finally, we found that co-colonizing strains may
also have beneﬁcial eﬀects, as illustrated by growth restoration
of the P. aeruginosa bioA mutant by K. pneumoniae and E. coli
(Figure 5).
Studies on microbial interactions have already revealed the
role of the Pseudomonas quinolone signal (PQS) biosynthesis
pathway in the inhibition of S. aureus growth. It has been demon-
strated that 2-heptyl-4-quinolone N-oxide (HQNO), one of the
ﬁnal products of the pqs pathway, suppresses growth of Gram-
positive bacteria, but not of Gram-negative bacteria (Machan
et al., 1992). In aerobic conditions, HQNO binds to quinone-
reacting cytochromes and inhibits respiratory electron transfer
from quinone to cytochromes (Magalon et al., 1998; Toyofuku
et al., 2008). The present study conﬁrms the role of the PQS-
biosynthesis pathway in the direct competition with S. aureus.
Indeed, pqsC acts at the beginning of the metabolic PQS-pathway
and its inactivation leads to the absence of all HAQs includ-
ing PQS, 2-heptyl-4-quinolone (HHQ), as well as their N-oxide
derivatives. The pqsC mutant identiﬁed in our screening was
unable to inhibit growth of S. aureus in rich medium. The wild-
type phenotype was partially restored in the pqsC mutant by
complementation with plasmid-encoded copies of the pqsCDE
genes. The partial complementation can be explained by a gene
dosage eﬀect due to overexpression from the constitutive pro-
moter present on the vector plasmid pIApX2. In addition, we
FIGURE 3 | Role of the P. aeruginosa carB gene during competition
with S. aureus. (A) Spots of P. aeruginosa cultures were deposited on LB
agar plates seeded with a lawn of S. aureus strain COL. (B) Rhamnolipid
production by the wild-type PA14 and the carB-disrupted PA14 strains. No
difference was observed between the two strains within duplicates indicating
that the Rhl quorum-sensing (QS) is not affected in the mutant. (C) Elastase
production by the wild-type PA14 and the carB-disrupted PA14. Error bars
indicate standard deviations calculated from three experimental replicates.
(D) Quantification of PQS production during competition with S. aureus. The
carB mutant and the wild-type PA14 strains were both incubated with the
competitor and with the PAO1  pqsA pqsA::lux reporter strain. PQS
production was evaluated by quantification of the luminescence produced by
the reporter strain in response to the amount of PQS in the medium.
Luminescence was quantified after 6 h of incubation at 37◦C. Error bars are
standard deviations calculated on duplicate.
Frontiers in Microbiology | www.frontiersin.org 8 April 2015 | Volume 6 | Article 321
Beaume et al. Interactions between respiratory pathogens
FIGURE 4 | Role of the carB, purF and bioAmutations during bacterial
interactions between P. aeruginosa and other respiratory pathogens.
(A–D) Spots of P. aeruginosa cultures were deposited on LB agar (A,B) or MH
agar plates (C,D) seeded with a lawn of S. aureus, K. pneumoniae, B.
cenocepacia, or E. coli. Bacterial lawns were composed by viable cells (VC)
from overnight cultures or by supernatants (S) of filtrated overnight cultures.
demonstrated that the PQS-pathway does not play a role under
hypoxic conditions. This result was not unexpected since under
hypoxic conditions, the aerobic respiratory chain is not func-
tional and cannot be inhibited by HQNO (Machan et al., 1992).
Furthermore, HQNO and PQS seem to be produced only under
aerobic conditions due to the oxygen requirement of the PqsH
mono-oxygenase to catalyze the ﬁnal conversion of HHQ to
PQS (Schertzer et al., 2010). This suggests that in the thickened
mucous layers in the airways of CF patients, where low oxygen
concentrations are prevailing (Worlitzsch et al., 2002), HQNO
may play only a limited role in interference between P. aerug-
inosa and S. aureus. We can also hypothesize that the role of
the PQS-system on S. aureus is limited in mixed bioﬁlms, repre-
senting microaerophilic growth conditions. Nevertheless, HHQ
and PQS were identiﬁed in sputum samples from CF patients
(Collier et al., 2002; Palmer et al., 2005) indicating that maybe, in
the more oxygenated upper respiratory tract, HQNO might play
a more prominent role in growth inhibition of Gram-positive
bacteria.
Our results further suggest that the N-oxide derivatives of
HAQs are responsible primarily for the S. aureus growth inhi-
bition. As described above, the pqsH mutant was aﬀected in
the conversion of HHQ to PQS. PQS contributes to the posi-
tive feedback regulation of the pqsA-D genes via PqsR. Thus, a
defect in PQS production should lead to the absence (or major
decrease) of HHQ and HQNO in a pqsH mutant. In addition
our results showed a small residual activity of the pqsL mutant,
which displayed only a weak inhibition of S. aureus growth
both on agar and in liquid. PqsL is a putative mono-oxygenase
converting HHQ to HQNO, and PQS to its N-oxide deriva-
tive (Lepine et al., 2004). A pqsL mutant was shown to produce
increased amounts of PQS (D’Argenio et al., 2002), and maybe
also of other HAQs, suggesting that the non-N-oxide deriva-
tives may also display a weak growth inhibitory eﬀect on S.
aureus.
In addition to the role of PQS, we demonstrated that the
P. aeruginosa carB gene is required for direct competition
with S. aureus. Without uracil, the carB-disrupted strain exhib-
ited an alteration in its capacity to inhibit S. aureus growth.
However, the growth of this mutant appeared to be slightly
aﬀected. Nevertheless, when we added uracil in the medium,
the growth of the carB-disrupted strain was totally restored, but
the inhibition of S. aureus growth was still diminished. Previous
reports suggested that uracil inﬂuences all three QS-systems
in P. aeruginosa (i.e., las, rhl, pqs; Ueda et al., 2009). Since
uracil is the ﬁnal product of the biosynthesis pathway contain-
ing the carB gene, we tested if the phenotype exhibited by the
carB-disrupted strain can be linked to QS. However, pheno-
typic analysis of QS-dependent traits showed that none of the
three QS-systems was aﬀected in the carB-disrupted strain. This
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FIGURE 5 | Schematic summary of the growth phenotypes displayed by the carB, purF, and bioA mutants during interactions with other respiratory
pathogens. Metabolic pathways are based on the Kyoto Encyclopedia of Genes and Genomes databases. Open circles represent no growth, whereas filled circles
indicate growth of P. aeruginosa mutants.
indicates that a QS-unrelated mechanism was responsible for
reduced inhibition of S. aureus growth in the carB-disrupted
strain.
Interestingly, the carB gene also appeared essential for the
exploitative competition between P. aeruginosa and S. aureus,
as well as with B. cepacia and K. pneumoniae. These results
suggest that carB is involved in the competition for resources
between P. aeruginosa and these three competitors. CarB is
an enzyme catalyzing the transformation of L-glutamine into
carbamoyl-phosphate, an intermediate in the pyrimidine, argi-
nine, and proline metabolisms (Figure 5). We show that the
phenotype of the carB-disrupted strain can be restored by
the addition of uracil, but not of arginine, demonstrating
that the role of the carB gene in the exploitative competi-
tion can be associated to the pyrimidine biosynthesis path-
way.
In addition to carB, the purF gene also appeared to be
an essential gene for exploitative competition. Interestingly,
growth of the purF mutant was not aﬀected in the presence
of Gram-positive bacteria (S. aureus and S. epidermidis)
but was severely aﬀected in grow in the presence of the
Gram-negative strains tested (B. cenocepacia, K. pneumoniae,
E. coli). The purF gene encodes an amidophosphoribosyl-
transferase involved in the conversion of L-Glutamine into
5-Phospho-ribosylamine, a primary product of the purine
metabolism (Figure 5). Taken together, these results high-
light the essential role of nucleic acid biosynthesis path-
ways for exploitative competition. Interestingly, the purine
and pyrimidine synthesis pathways were also shown to be
important for colonization of the mouse intestine by E. coli
(Vogel-Scheel et al., 2010), an environment where invad-
ing organisms have to compete with resident microbial
ﬂora.
Finally, we identiﬁed beneﬁcial interactions between P. aerug-
inosa and other lung co-colonizing species via the biotin syn-
thesis pathway. Whereas a P. aeruginosa bioA-disrupted mutant
was unable to grow on rich medium, the presence of K. pneu-
moniae and E. coli complemented the growth defect of this
strain (Figure 5). In other words, the presence of K. pneumoniae
and E. coli can be beneﬁcial to P. aeruginosa when biotin
supply is limited. However, the molecular basis of this beneﬁcial
interaction remains to be elucidated.
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Conclusion
Understanding the interactions between the various bacterial
communities colonizing the CF-airways is of considerable
importance as interactions can potentially aﬀect the metabolism
of pathogens, alter the population structure and eventually inﬂu-
ence disease progression. It is clear from our experiments that
complex interactions take place between CF-lung colonizing
species which may lead to profound changes in bacterial com-
munity structures in CF-patients. Detrimental and beneﬁcial
interactions not only modulate the richness and the diversity of
species but also create a complex environment in which bacterial
species need to adapt to co-colonizing species aiming to increase
their relative ﬁtness. The metabolic pathways involved in these
complex interactions could potentially be exploited tomanipulate
microbial population structure to improve the clinical outcome of
chronic infectious.
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